MedTrace Logo

Extracorporeal Life Support in Cardiogenic Shock

NCT03637205 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2024-12-13

No results posted yet for this study

Summary

The aim of the study is to examine whether treatment with extracorporeal life support (ECLS) in addition to revascularization with percutaneous coronary intervention (PCI) or alternatively coronary artery bypass grafting (CABG) and optimal medical treatment is beneficial in comparison to no ECLS in patients with severe infarctrelated cardiogenic shock with respect to 30-day mortality

Conditions

  • Acute Myocardial Infarction
  • Cardiogenic Shock

Interventions

PROCEDURE

ECLS insertion

After diagnostic angiography the culprit lesion should be identified and revascularization (preferably by PCI, alternatively CABG) should be planned. ECLS insertion should be performed preferably before revascularization

OTHER

Revascularisation and optimal medical treatment

After diagnostic angiography the culprit lesion should be identified and revascularization (preferably by PCI, alternatively CABG) should be planned.

Sponsors & Collaborators

  • Heart Center Leipzig - University Hospital

    collaborator OTHER

  • IHF GmbH - Institut für Herzinfarktforschung

    collaborator OTHER

  • Helios Health Institute GmbH

    lead OTHER

Principal Investigators

  • Holger Thiele, MD · Director, Department of Cardiology, Heart Center Leipzig

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-20
Primary Completion
2022-12-23
Completion
2024-09-02

Countries

  • Germany
  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03637205 on ClinicalTrials.gov